Meta Pixel

News and Announcements

OZ Medicann to expand corporate structure enhancing its ability to provide products for the Australian and  International markets

  • Published February 28, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

OZ Medicann Pty Ltd is enhancing its ability to provide class-leading, patient-centric, development and supply medicinal cannabis products for the Australian and  International markets

The restructure which will involve the creation of a new head company, Oz Medicann Group Pty Ltd, under which will reside:

  • Oz Medicann P/L focused primarily on the cultivation, research, production and supply of
    medicinal cannabis solutions
  • Educann P/L which will deliver education, certification and accreditation to the medical
    practitioners and medicinal cannabis prescribers, and
  • Hemp OZ P/L commercialise related products and services that are derived from the cannabis
    plant.

All entities will generate sustainable revenue that will fund the short and medium and longer terms growth of the Group.

Unlike other medicinal cannabis companies, the OZ Medicann Group will control the entire medicinal cannabis supply chain, from seedling to researcher to patient. The objective of the OZ Medicann Group is to deliver the highest quality medicinal and therapeutic solutions to those who most need them the most – the Patients. With its focus on the sustainable production of high-quality medicinal cannabis solutions, the company will derive revenue from all sources in order to support this outcome.

The OZ Medicann Group is also pleased to announce the appointment of Lucy Haslam to its Board of Directors. Having Lucy on the Board further cements the Group’s commitment to patient-centric research and production and supply of medicinal cannabis solutions. Lucy is the leading advocate and driving force behind the legalisation of medicinal cannabis in Australia and we are thrilled to have Lucy join our team.

The OZ Medicann Group is also pleased to announce, in partnership with United in Compassion, the commencement soon of the largest patient-centric research on medicinal cannabis use in this country. A final announcement will be made shortly on the research partner who will undertake the survey.

The Group’s licence applications are with the Office of Drug Control and are being assessed for production, supply and research. The Group’s growing facility preparations are underway anticipated for quarter 4.

 

About OZ Medicann

OZ Medicann is a leading Australian Cannabis and Hemp cultivator that produces medicinal solutions, consumer products and education programs for medical practitioners.

Request Offer

Capital Insights
Navigating the Future of Capital: Insights from MENA’s VC and PE Leaders

The venture capital and private equity landscape in the MENA (Middle East and North Africa) region is experiencing dynamic shifts, driven by rapid technological advancements, evolving investor demands, and unique regional priorities. A recent panel featuring prominent figures in the MENA investment scene offered a glimpse into these transformations, highlighting key trends for founders and […]

Capital Insights
Web3’s Maturing Landscape and Trillion-Dollar Opportunities

The narrative around Web3 is rapidly evolving. While many still associate it primarily with the speculative highs and lows of cryptocurrencies, the reality is a rapidly maturing ecosystem brimming with genuine innovation and significant investment potential. As Steve Torso, Co-founder & Managing Director of Wholesale Investor & CapitalHQ, aptly puts it, “It’s only got 8% […]

Join over 45,000+ sophisticated investors

Join Now